查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771311

细胞计数法市场：行业趋势和全球预测 - 依细胞仪类型、公司规模、地区和主要企业

Cell Cytometry Market: Industry Trends and Global Forecasts - Distribution by Type of Cell Cytometer, Company Size and Geographical Regions and Leading Players
出版日期: | 出版商: Roots Analysis | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

全球细胞计数法市场：概览

预计到2035年，全球细胞计数法市场规模将从目前的18.2亿美元成长至52.6亿美元，预测期内的年复合成长率为10.1%。

市场区隔包括根据以下参数进行的市场规模和机会分析：

细胞计数法类型

  • 高通量流式细胞仪
  • 影像流式细胞仪

公司规模

  • 小型
  • 小型
  • 中型
  • 大型
  • 超大型大

地区

  • 北美（美国、加拿大、墨西哥）
  • 欧洲（法国、德国、义大利、西班牙、英国、世界其他地区）
  • 亚太地区（中国、日本、印度、韩国、澳洲、俄罗斯、泰国、马来西亚、印尼、世界其他地区）
  • 中东和北非（伊朗、沙乌地阿拉伯、埃及）
  • 拉丁美洲（巴西、阿根廷、世界其他地区）

全球细胞计数法市场：成长与趋势

细胞计数法是一种用于分析和表征细胞的分析技术。近年来，该技术在医疗保健和製药行业获得了广泛的支持，尤其是在识别生物标记和评估药效学-药物动力学关係方面。此外，细胞计数法在评估标靶治疗药物对免疫系统的影响方面也发挥关键作用。现代细胞计数法能够详细表征免疫细胞群及其对各种疾病的反应，使其成为分析生物样本的多功能工具。随着全球慢性病的增多，对细胞计数法等先进生物分析技术的需求持续成长。

细胞计数法市场-IMG1

细胞计数法应用范围广泛，涵盖基础研究、药物研发和临床诊断，是阐明免疫反应、追踪疾病进展和揭示细胞机制的宝贵工具。因此，许多产业参与者正致力于开发具有高通量、多重分析选项和增强资料分析工具的先进细胞计数法技术。

全球细胞计数法市场：关键洞察

本报告深入探讨了全球细胞计数法市场的现状，并识别了行业内的潜在成长机会。报告的主要调查结果包括：

  • 目前，超过 220 种细胞计数法可用于广泛的临床和研发应用，其中大多数由美国公司开发。
  • 市场格局的特点是，细胞计数法市场种类繁多，它们利用多种检测机制和颜色通道对细胞进行计数和分选。
  • 大多数（91%）使用少于 10个颜色通道的高通量流式细胞仪由美国公司开发。
细胞计数法市场-IMG2
  • 为了建立竞争优势，各利益相关者正积极努力将先进功能融入各自的流式细胞仪产品组合，并遵循不断发展的行业基准。
  • 随着流式细胞仪的普及，多家业界参与者已签署多项高通量流式细胞仪和图像流式细胞仪协议。
  • 过去一年的合作数量最多，其中大部分是分销协议和收购。
  • 值得注意的是，总部位于北美的公司（75%）进行了收购。
  • 一些投资者意识到细胞计数法领域的机会，已投资数百万美元，用于支持具有先进功能的流式细胞仪的开发。
  • 据报道，大部分创投轮次（约 90%）是透过 B 轮和 D 轮融资获得的，其中大多数为 B 轮融资。
  • 与工业界和非工业界利害关係人一起参与各种全球活动，探讨细胞计数法产业的研究成果、相关挑战和机会。
  • 该领域 75%的网路研讨会是在过去 2-3年内举办的，其中大部分由 Labroots 主办。
  • 过去 5年，学术界和工业界利益相关者已授予/提交了 1,500 多项与细胞计数法相关的专利，其中大部分为专利申请。
  • 预计该市场将以 10.1%的年复合成长率成长。预计的市场机会可能均匀分布在各种类型的流式细胞仪产品中，北美地区可能占据目前的大部分市场占有率。
细胞计数法市场-IMG3

细胞计数法市场参与者

  • Agilent
  • Beckton Dickinson
  • Beckman Coulter Life Sciences
  • Bio-Rad
  • Chemometec
  • Milkotronic
  • PerkinElmer
  • Sartorius
  • Sony Biotechnology
  • Thermo Fisher Scientific
  • Union Biometrica

全球细胞计数法市场：关键细分市场

根据细胞计数法类型，市场细分为高通量细胞计数法和图像细胞分析仪。目前，高通量细胞分析仪在全球细胞分析仪市场中占有最大占有率（约60%）。然而，由于对用于亚细胞形态可视化的高分辨率分析工具的需求不断成长，预计影像细胞分析仪市场在预测期内将以更高的年复合成长率成长。

依公司规模划分，市场可分为小型、小型、中型、大型及超大型公司。目前，超大型公司在细胞分析仪市场中占有最高占有率（约40%）。此外，由于强大的研发能力、广泛的销售网路、成熟的品牌声誉以及大型公司在该领域的持续努力，该市场预计将以相对更高的年复合成长率成长。

依主要地区划分，市场分为北美、欧洲、亚太地区及世界其他地区。目前，北美（约60%）在细胞分析仪市场中占据主导地位，占据最大的收入占有率。然而，预计亚太地区市场在预测期内的年复合成长率将高达 14%。

本报告研究了全球细胞计数法市场，并提供了市场概况、依细胞仪类型、依公司规模划分的趋势、依地区划分的趋势以及参与市场的公司概况。

目录

第1章 简介

第2章 执行摘要

第3章 简介

  • 章节概述
  • 细胞计数法
  • 细胞计数法的优点与局限性
  • 细胞计数法的整体趋势

第4章 高通量流式细胞仪：市场模式

  • 章节概述
  • 高通量流式细胞仪：市场格局
  • 高通量流式细胞仪：开发商格局

第5章 产品竞争力分析：高通量流式细胞仪

  • 章节概述
  • 假设/关键参数
  • 研究方法
  • 产品竞争力分析

第6章 影像细胞分析仪：市场格局

  • 章节概述
  • 影像细胞分析仪：市场格局
  • 影像细胞分析仪：开发商格局

第7章 产品竞争力分析：影像细胞分析仪

  • 章节概述
  • 假设/关键参数
  • 研究方法
  • 产品竞争力分析

第8章 全球细胞计数法：公司简介

  • 章节概述
  • Agilent
  • Beckman Coulter Life Sciences
  • Becton Dickinson
  • Bio-Rad
  • Chemometec
  • Milkotronic
  • Nexcelom Bioscience
  • Sartorius
  • Sony Biotechnology
  • ThermoFisher Scientific
  • Union Biometrica

第9章 全球细胞计数法：合作伙伴关係与合作

  • 章节概述
  • 合作模式
  • 合作伙伴关係与合作列表

第10章 最新进展

  • 章节概述
  • 全球细胞计数法：资金与投资分析
  • 全球细胞计数法：全球事件分析
  • 结论

第11章 专利分析

  • 章节概述
  • 研究范围与研究方法
  • 细胞计数法：专利基准分析
  • 细胞计数法：专利估值分析
  • 被引用次数最高的专利

第12章 市场预测

  • 章节概述
  • 关键假设与研究方法
  • 2035年全球细胞计数法市场
    • 全球细胞计数法市场：依细胞分析仪类型
    • 全球细胞计数法市场：依公司规模
    • 全球细胞计数法市场：依主要地区

第13章 结论

第14章 执行洞察

第15章 附录1：表格资料

第16章 附录2：公司与组织清单

Product Code: RA100398

GLOBAL CELL CYTOMETRY MARKET: OVERVIEW

As per Roots Analysis, the global cell cytometry market is estimated to grow from USD 1.82 billion in the current year to USD 5.26 billion by 2035, at a CAGR of 10.1% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Cell Cytometer

  • High Throughput Flow Cytometers
  • Image Cytometers

Company Size

  • Very Small
  • Small
  • Mid-Sized
  • Large
  • Very Large

Geographical Regions

  • North America (US, Canada, Mexico)
  • Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia, Rest of Asia Pacific)
  • Middle East and North Africa (Iran, Saudi Arabia and Egypt)
  • Latin America (Brazil, Argentina, Rest of Latin America)

GLOBAL CELL CYTOMETRY MARKET: GROWTH AND TRENDS

Cell cytometry is an analytical technique used for the analysis and characterization of cells. Recently, this technique has gained significant traction within the healthcare and pharmaceutical industries, particularly for biomarker identification and for assessing the relationship between pharmacodynamics and pharmacokinetics. Additionally, cell cytometers play a crucial role in evaluating the effects of targeted therapies on the immune system. Modern cell cytometers enable detailed characterization of immune cell populations and their responses to various diseases, making them highly versatile tools for analyzing biological samples. With the global rise in chronic diseases, the demand for advanced bioanalytical techniques like cell cytometry is continuously increasing.

Cell Cytometry Market - IMG1

Given the wide applications of cell cytometry ranging from basic research to drug discovery and clinical diagnostics, it has become an invaluable tool for unraveling immune responses, tracking disease progression, and understanding cellular mechanisms. As a result, many industry players are focusing on research efforts to develop advanced cell cytometry technologies featuring high-throughput capabilities, multiplexing options and enhanced data analysis tools.

GLOBAL CELL CYTOMETRY MARKET: KEY INSIGHTS

The report delves into the current state of global cell cytometry market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Presently, over 220 cell cytometers are currently available for use across wide range of clinical studies and research applications; majority of these have been developed by companies based in the US.
  • The market landscape features a variety of cell cytometers that make use of multiple detection mechanisms and color channels to count and sort cells.
  • Majority (91%) of the high throughput flow cytometers that use less than 10 color channels have been developed by players headquartered in the US.
Cell Cytometry Market - IMG2
  • In pursuit of building a competitive edge, stakeholders are making an active effort to incorporate advanced features in their respective portfolio of cytometers and comply with evolving industry benchmarks.
  • With the growing adoption of cytometers, several industry players have signed multiple agreements for high throughput flow cytometers and image cytometers.
  • The maximum number of partnerships were reported in the previous year; most of these deals were distribution agreements and acquisitions.
  • Notably, all acquisitions in the industry have been undertaken by players headquartered in North America (75%); majority of these deals are focused on the expansion of product portfolio.
  • Having realized the opportunity in the cell cytometry segment, several investors have collectively invested multi-million dollars to aid the development of cytometers with advanced features.
  • Majority (~90%) of the amount raised via venture rounds was reported through venture series B and D; of these, most of the instances reported were of venture series B funding round.
  • Both industry and non-industry players have participated in various global events to discuss the research outcomes, affiliated challenges as well as opportunities in the cell cytometry industry.
  • 75% of the webinars in this domain have been organized in the last couple of years; of these, majority were organized by Labroots.
  • More than 1,500 patents related to cell cytometers have been granted / filed by academia and industry stakeholders in the last five years; majority of these were patent applications.
  • The market is expected to grow at a CAGR of 10.1%; the projected market opportunity is likely to be well distributed across different types of cytometers; North America is likely to capture majority of the current market share.
Cell Cytometry Market - IMG3

Example Players in the Cell Cytometry Market

  • Agilent
  • Beckton Dickinson
  • Beckman Coulter Life Sciences
  • Bio-Rad
  • Chemometec
  • Milkotronic
  • PerkinElmer
  • Sartorius
  • Sony Biotechnology
  • Thermo Fisher Scientific
  • Union Biometrica

GLOBAL CELL CYTOMETRY MARKET: KEY SEGMENTS

High Throughput Cell Cytometers Segment Occupies the Largest Share of the Cell Cytometry Market

Based on the type of cell cytometers, the market is segmented into high throughput cell cytometers and image cytometers. At present, high throughput cell cytometers segment holds the maximum (~60%) share of the global cell cytometry market. However, due to the rising demand for high resolution analytical tools for the sub-cellular visualization of cell morphology, image cytometers segment is expected to grow at a higher CAGR during the forecast period.

By Company Size, Very Large Companies is the Fastest Growing Segment of the Global Cell Cytometry Market

Based on the company size, the market is segmented into very small, small, mid-size, large, and very large companies. Currently, very large segment captures the highest proportion (~40%) of the cell cytometry market. Further, this segment is likely to grow at a relatively higher CAGR due to the ongoing efforts of large companies in this domain, in addition to their strong R&D capabilities, extensive distribution networks and established brand reputation.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America (~60%) dominates the cell cytometry market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 14% during the forecast period.

GLOBAL CELL CYTOMETRY MARKET

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global cell cytometry market, focusing on key market segments, including [A] type of cell cytometer, [B] company size and [C] key geographical regions.
  • High Throughput Flow Cytometers Market Landscape: A comprehensive evaluation of high throughput flow cytometers, considering various parameters, such as [A] type of high throughput flow cytometer, [B] throughput rate (wells per minute), [C] detection rate, [D] type of plate format(s), [E] number of color channels, [F] number of laser channels, [G] number of detection channels, [H] sample volume (in µl), [I] type of detection mechanism(s) and [J] application(s). Additionally, the section presents a comprehensive evaluation of high throughput flow cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading players.
  • Product Competitiveness Analysis: An insightful competitive analysis of high throughput flow cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
  • Image Cytometers Market Landscape: A comprehensive evaluation of image cytometers, considering various parameters, such as [A] type of image cytometer, [B] processing time, [C] type of plate format(s), [D] output format(s), [E] sample volume and [F] application(s). Additionally, a comprehensive evaluation of image cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [E] leading players (in terms of number of products being offered).
  • Product Competitiveness Analysis: An insightful competitive analysis of image cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
  • Company Profiles: In-depth profiles of companies engaged in the development / commercialization of cell cytometers, focusing on [A] company overview and [B] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution of partnership activity.
  • Recent Developments: A detailed analysis of recent developments / trends related to global cell cytometry domain, providing key insights on the funding activity in this domain, based on several relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD Million), [D] most active players and [E] most active investors. Additionally, the section presents a detailed evaluation of the global events attended by the participants, based on several relevant parameters, such as [A] year of event, [B] event platform, [C] type of event, [D] most active organizers and [E] most active organizations.
  • Patent Analysis: An in-depth analysis of patents filed / granted for cell cytometry, based on various relevant parameters, such as [A] publication year, [B] geography, [C] CPC symbols, [D] emerging focus areas, [E] type of applicant, [F] leading industry players and [G] patent valuation analysis.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Cell Cytometry
    • 3.2.1. Flow Cytometry
      • 3.2.1.1. High Throughput Flow Cytometry
    • 3.2.2 Image Cytometry
  • 3.3. Advantages and Limitations of Cell Cytometry
  • 3.4. Prevalent Trends Related to Cell Cytometry
    • 3.4.1. Key Historical Trends
    • 3.4.2. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. High Throughput Flow Cytometers: Overall Market Landscape
    • 4.2.1. Analysis by Type of High Throughput Flow Cytometer
    • 4.2.2. Analysis by Throughput Rate
    • 4.2.3. Analysis by Detection Rate
    • 4.2.4. Analysis by Type of Plate Format(s)
    • 4.2.5. Analysis by Number of Color Channels
    • 4.2.6. Analysis by Number of Detection Channels
    • 4.2.7. Analysis by Number of Laser Channels
    • 4.2.8. Analysis by Sample Volume
    • 4.2.9. Analysis by Type of Detection Mechanism(s)
    • 4.2.10. Analysis by Application(s)
  • 4.3. High Throughput Flow Cytometers: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

  • 5.1. Chapter Overview
  • 5.2. Assumptions / Key Parameters
  • 5.3. Methodology
  • 5.4. Product Competitiveness Analysis
    • 5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America
    • 5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia-Pacific

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Image Cytometers: Overall Market Landscape
    • 6.2.1. Analysis by Type of Image Cytometer
    • 6.2.2. Analysis by Processing Time
    • 6.2.3. Analysis by Type of Plate Format(s)
    • 6.2.4. Analysis by Output Format(s)
    • 6.2.5. Analysis by Sample Volume
    • 6.2.6. Analysis by Application(s)
  • 6.3. Image Cytometers: Developer Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis by Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

  • 7.1. Chapter Overview
  • 7.2. Assumptions / Key Parameters
  • 7.3. Methodology
  • 7.4. Product Competitiveness Analysis
    • 7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
    • 7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia-Pacific

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Agilent
    • 8.2.1. Company Overview
    • 8.2.2. Recent Developments and Future Outlook
  • 8.3. Beckman Coulter Life Sciences
    • 8.3.1. Company Overview
    • 8.3.2. Recent Developments and Future Outlook
  • 8.4. Becton Dickinson
    • 8.4.1. Company Overview
    • 8.4.2. Recent Developments and Future Outlook
  • 8.5. Bio-Rad
    • 8.5.1. Company Overview
    • 8.5.2. Recent Developments and Future Outlook
  • 8.6. Chemometec
    • 8.6.1. Company Overview
    • 8.6.2. Recent Developments and Future Outlook
  • 8.7. Milkotronic
    • 8.7.1. Company Overview
    • 8.7.2. Recent Developments and Future Outlook
  • 8.8. Nexcelom Bioscience
    • 8.8.1. Company Overview
    • 8.8.2. Recent Developments and Future Outlook
  • 8.9. Sartorius
    • 8.9.1. Company Overview
    • 8.9.2. Recent Developments and Future Outlook
  • 8.10. Sony Biotechnology
    • 8.10.1. Company Overview
    • 8.10.2. Recent Developments and Future Outlook
  • 8.11. ThermoFisher Scientific
    • 8.11.1. Company Overview
    • 8.11.2. Recent Developments and Future Outlook
  • 8.12. Union Biometrica
    • 8.12.1. Company Overview
    • 8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. List of Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Most Active Players: Analysis by Number of Partnerships
    • 9.3.4. Regional Analysis
    • 9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS

  • 10.1. Chapter Overview
  • 10.2. Global Cell Cytometry: Funding and Investment Analysis
    • 10.2.1. Types of Funding
    • 10.2.2. Analysis by Year of Investment
    • 10.2.3. Analysis by Type of Funding
    • 10.2.4. Analysis by Amount Invested
    • 10.2.5. Most Active Players: Analysis by Number of Funding Instances
    • 10.2.6. Most Active Players: Analysis by Amount Raised
    • 10.2.7. Most Active Investors: Analysis by Number of Funding Instances
  • 10.3. Global Cell Cytometry: Global Event Analysis
    • 10.3.1. Analysis by Year of Event
    • 10.3.2. Analysis by Event Platform
    • 10.3.3. Analysis by Type of Event
    • 10.3.4. Analysis by Geography
    • 10.3.5. Most Active Event Organizers: Analysis by Number of Events
    • 10.3.6. Most Active Organizations: Analysis by Number of Participants
  • 10.4. Concluding Remarks

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
    • 11.2.1. Analysis by Type of Patent
    • 11.2.2. Analysis by Patent Publication Year
    • 11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
    • 11.2.4. Analysis by Geographical Location
    • 11.2.5. Analysis by CPC Symbols
    • 11.2.6. Analysis by Type of Organization
    • 11.2.7. Leading Industry Players: Analysis by Number of Patents
    • 11.2.8. Leading Non-Industry Players: Analysis by Number of Patents
    • 11.2.9. Leading Individual Assignees: Analysis by Number of Patents
  • 11.3. Cell Cytometry: Patent Benchmarking Analysis
    • 11.3.1. Analysis by Patent Characteristics
  • 11.4. Cell Cytometry: Patent Valuation Analysis
  • 11.5. Leading Patents by Number of Citations

12. MARKET FORECAST

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Cell Cytometry Market, Till 2035
    • 12.3.1. Global Cell Cytometry Market: Distribution by Type of Cell Cytometer
      • 12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035
      • 12.3.1.2. Cell Cytometry Market for Image Cytometers, Till 2035
    • 12.3.2. Global Cell Cytometry Market: Distribution by Company Size
      • 12.3.2.1. Cell Cytometry Market for Very Small Companies, Till 2035
      • 12.3.2.2. Cell Cytometry Market for Small Companies, Till 2035
      • 12.3.2.3. Cell Cytometry Market for Mid-sized Companies, Till 2035
      • 12.3.2.4. Cell Cytometry Market for Large Companies, Till 2035
      • 12.3.2.5. Cell Cytometry Market for Very Large Companies, Till 2035
    • 12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions
      • 12.3.3.1. Cell Cytometry Market in North America, Till 2035
      • 12.3.3.2. Cell Cytometry Market in Europe, Till 2035
      • 12.3.3.3. Cell Cytometry Market in Asia-Pacific, Till 2035
      • 12.3.3.4. Cell Cytometry Market in Rest of the World, Till 2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 High Throughput Flow Cytometers: Information on Type of High Throughput Flow Cytometer and Throughput Rate
  • Table 4.2 High Throughput Flow Cytometers: Information on Detection Rate
  • Table 4.3 High Throughput Flow Cytometers: Information on Type of Plate Format(s)
  • Table 4.4 High Throughput Flow Cytometers: Information on Number of Color Channels
  • Table 4.5 High Throughput Flow Cytometers: Information on Number of Detection Channels
  • Table 4.6 High Throughput Flow Cytometers: Information on Number of Laser Channels and Patented Technology
  • Table 4.7 High Throughput Flow Cytometers: Information on Availability of Automation, Availability of Automatic Sampling and Sample Volume
  • Table 4.8 High Throughput Flow Cytometers: Information on Type of Detection Mechanism(s)
  • Table 4.9 High Throughput Flow Cytometers: Information on Application(s)
  • Table 4.10 High Throughput Flow Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 6.1 Image Cytometer: Information on Type of Image Cytometer
  • Table 6.2 Image Cytometers: Information on Processing Time
  • Table 6.3 Image Cytometer: Information on Type of Plate Format(s) and Magnification
  • Table 6.4 Image Cytometer: Information on Output Format(s)
  • Table 6.5 Image Cytometer: Information on Sample Volume
  • Table 6.6 Image Cytometers: Information on Application(s)
  • Table 6.7 Image Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 8.1 List of Companies Profiled
  • Table 8.2 Agilent: Company Overview
  • Table 8.3 Agilent: Recent Developments and Future Outlook
  • Table 8.4 Beckman Coulter Life Sciences: Company Overview
  • Table 8.5 Beckman Coulter Life Sciences: Recent Developments and Future Outlook
  • Table 8.6 Becton Dickinson: Company Overview
  • Table 8.7 Becton Dickinson: Recent Developments and Future Outlook
  • Table 8.8 Bio-Rad: Company Overview
  • Table 8.9 Bio-Rad: Recent Developments and Future Outlook
  • Table 8.10 Chemometec: Company Overview
  • Table 8.11 Chemotec: Recent Developments and Future Outlook
  • Table 8.12 Milkotronic: Company Overview
  • Table 8.13 Nexcelom Bioscinces: Company Overview
  • Table 8.14 Sartorius: Company Overview
  • Table 8.15 Sartorius: Recent Developments and Future Outlook
  • Table 8.16 Sony Biotechnology: Company Overview
  • Table 8.17 Thermo Fischer Scientific: Company Overview
  • Table 8.18 Thermo Fischer Scientific: Recent Developments and Future Outlook
  • Table 8.19 Union Biometrica: Company Overview
  • Table 8.20 Union Biometrica: Recent Developments and Future Outlook
  • Table 9.1 Global Cell Cytometry: List of Partnerships and Collaborations, Since 2017
  • Table 10.1 Global Cell Cytometry: List of Funding and Investments, Since 2017
  • Table 10.2 Global Cell Cytometry: List of Global Events, Since 2018
  • Table 11.1 Patent Analysis: Prominent CPC Symbols
  • Table 11.2 Patent Analysis: List of Top CPC Symbols
  • Table 11.3 Patent Analysis: Most Popular CPC Symbols
  • Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 15.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
  • Table 15.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
  • Table 15.3 High Throughput Flow Cytometers: Distribution by Detection Rate
  • Table 15.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
  • Table 15.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
  • Table 15.6 High Throughput Flow Cytometers: Distribution by Number of Detection Channels
  • Table 15.7 High Throughput Flow Cytometers: Distribution by Number of Laser Channels
  • Table 15.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
  • Table 15.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
  • Table 15.10 High Throughput Flow Cytometers: Distribution by Application(s)
  • Table 15.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
  • Table 15.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
  • Table 15.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
  • Table 15.14 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
  • Table 15.15 Image Cytometers: Distribution by Type of Image Cytometer
  • Table 15.16 Image Cytometers: Distribution by Processing Time
  • Table 15.17 Image Cytometers: Distribution by Type of Plate Format(s)
  • Table 15.18 Image Cytometers: Distribution by Output Format(s)
  • Table 15.19 Image Cytometers: Distribution by Sample Volume
  • Table 15.20 Image Cytometers: Distribution by Application(s)
  • Table 15.21 Image Cytometer Developers: Distribution by Year of Establishment
  • Table 15.22 Image Cytometer Developers: Distribution by Company Size
  • Table 15.23 Image Cytometer Developers: Distribution by Location of Headquarters
  • Table 15.24 Leading Image Cytometer Developers: Distribution by Number of Products Offered
  • Table 15.25 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2017
  • Table 15.26 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 15.27 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2017
  • Table 15.28 Most Active Players: Distribution by Number of Partnerships
  • Table 15.29 Partnerships and Collaborations: Regional Analysis
  • Table 15.30 Partnerships and Collaborations: Local and International Agreements
  • Table 15.31 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 15.32 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2017
  • Table 15.33 Funding and Investment Analysis: Distribution by Type of Funding
  • Table 15.34 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, Since 2017 (USD Million)
  • Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 15.36 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, Since 2017 (USD Million)
  • Table 15.37 Most Active Players: Distribution by Number of Funding Instances
  • Table 15.38 Most Active Players: Distribution by Amount Raised (USD Million)
  • Table 15.39 Most Active Investors: Distribution by Number of Funding Instances
  • Table 15.40 Global Events: Cumulative Half yearly Trend, Since 2018
  • Table 15.41 Global Events: Distribution by Event Platform
  • Table 15.42 Global Events: Distribution by Type of Event
  • Table 15.43 Global Events: Regional Distribution of Event
  • Table 15.44 Most Active Event Organizers: Distribution by Number of Events
  • Table 15.45 Most Active Organizations: Distribution by Number of Participants
  • Table 15.46 Patent Analysis: Distribution by Type of Patent
  • Table 15.47 Patent Analysis: Cumulative Distribution by Publication Year, Since 2020
  • Table 15.48 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, Since 2020
  • Table 15.49 Patent Analysis: Distribution by Geographical Location
  • Table 15.50 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, Since 2020
  • Table 15.51 Leading Industry Players: Distribution by Number of Patents
  • Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
  • Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
  • Table 15.54 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
  • Table 15.55 Patent Analysis: Year-wise Distribution of Patents by Age
  • Table 15.56 Cell Cytometry: Patent Valuation Analysis
  • Table 15.57 Global Cell Cytometry Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.58 Global Cell Cytometry Market: Distribution by Type of Cytometer
  • Table 15.59 Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.60 Cell Cytometry Market for Image Cytometers, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.61 Global Cell Cytometry Market: Distribution by Company Size
  • Table 15.62 Cell Cytometry Market for Very Small Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.63 Cell Cytometry Market for Small Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.64 Cell Cytometry Market for Mid-Sized Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.65 Cell Cytometry Market for Large Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.66 Cell Cytometry Market for Very Large Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.67 Global Cell Cytometry Market: Distribution by Key Geographical Regions
  • Table 15.68 Cell Cytometry Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.69 Cell Cytometry Market in Europe, Till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.70 Cell Cytometry Market in Asia-Pacific, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.71 Cell Cytometry Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: High Throughput Flow Cytometers Market Landscape
  • Figure 2.2 Executive Summary: Image Cytometers Market Landscape
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Funding and Investment Analysis
  • Figure 2.5 Executive Summary: Global Events
  • Figure 2.6 Executive Summary: Patent Analysis
  • Figure 2.7 Executive Summary: Market Forecast
  • Figure 3.1 Types of Cytometers
  • Figure 3.2 Advantages of Different Types of Cytometry
  • Figure 3.3 Limitations of Different Types of Cytometry
  • Figure 3.4 Google Trends: Historical Timeline
  • Figure 3.5 Google Trends: Geographical Activity
  • Figure 4.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
  • Figure 4.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
  • Figure 4.3 High Throughput Flow Cytometers: Distribution by Detection Rate
  • Figure 4.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
  • Figure 4.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
  • Figure 4.6 High Throughput Flow Cytometers: Distribution by Number of DetectionChannels
  • Figure 4.7 High Throughput Flow Cytometers: Distribution by Number of LaserChannels
  • Figure 4.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
  • Figure 4.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
  • Figure 4.10 High Throughput Flow Cytometers: Distribution by Application(s)
  • Figure 4.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
  • Figure 4.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
  • Figure 4.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
  • Figure 4.14 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
  • Figure 5.1 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in North America
  • Figure 5.2 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in Europe and Asia-Pacific
  • Figure 6.1 Image Cytometer: Distribution by Type of Image Cytometer
  • Figure 6.2 Image Cytometer: Distribution by Processing Time
  • Figure 6.3 Image Cytometer: Distribution by Type of Plate Format(s)
  • Figure 6.4 Image Cytometers: Distribution by Output Format(s)
  • Figure 6.5 Image Cytometers: Distribution by Sample Volume
  • Figure 6.6 Image Cytometer: Distribution by Application(s)
  • Figure 6.7 Image Cytometer Developers: Distribution by Year of Establishment
  • Figure 6.8 Image Cytometer Developers: Distribution by Company Size
  • Figure 6.9 Image Cytometer Developers: Distribution by Location of Headquarters
  • Figure 6.10 Leading Image Cytometer Developers: Distribution by Number of Products Offered
  • Figure 7.1 Product Competitiveness Analysis: Image Cytometers offered by Players based in North America
  • Figure 7.2 Product Competitiveness Analysis: Image Cytometers offered by Players based in Europe and Asia-Pacific
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2017
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2017
  • Figure 9.4 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.5 Partnerships and Collaborations: Regional Analysis
  • Figure 9.6 Partnerships and Collaborations: Local and International Agreements
  • Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2017
  • Figure 10.2 Funding and Investment Analysis: Distribution by Type of Funding
  • Figure 10.3 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, Since 2017 (USD Million)
  • Figure 10.4 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 10.5 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, Since 2017 (USD Million)
  • Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
  • Figure 10.7 Most Active Players: Distribution by Amount Raised (USD Million)
  • Figure 10.8 Most Active Investors: Distribution by Number of Funding Instances
  • Figure 10.9 Global Events: Cumulative Half yearly Trend, Since 2018
  • Figure 10.10 Global Events: Distribution by Event Platform
  • Figure 10.11 Global Events: Distribution by Type of Event
  • Figure 10.12 Global Events: Regional Distribution of Events
  • Figure 10.13 Most Active Event Organizers: Distribution by Number of Events
  • Figure 10.14 Most Active Organizations: Distribution by Number of Participants
  • Figure 11.1 Patent Analysis: Distribution by Type of Patent
  • Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, Since 2020
  • Figure 11.3 Patent Analysis: Cumulative Distribution by Annual Number of Granted
  • Figure 11.4 Patent Analysis: Distribution by Geographical Location
  • Figure 11.5 Patent Analysis: Distribution by CPC Symbols
  • Figure 11.6 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, Since 2020
  • Figure 11.7 Leading Industry Players: Distribution by Number of Patents
  • Figure 11.8 Leading Non-Industry Players: Distribution by Number of Patents
  • Figure 11.9 Leading Individual Assignees: Distribution by Number of Patents
  • Figure 11.10 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
  • Figure 11.11 Patent Analysis: Year-wise Distribution of Patents by Age
  • Figure 11.12 Cell Cytometry: Patent Valuation Analysis
  • Figure 12.1 Global Cell Cytometry Market, Till 2035 (USD Million)
  • Figure 12.2 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer
  • Figure 12.3 Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035 (USD Million)
  • Figure 12.4 Cell Cytometry Market for Image Cytometers, Till 2035 (USD Million)
  • Figure 12.5 Global Cell Cytometry Market: Distribution by Company Size
  • Figure 12.6 Cell Cytometry Market for Very Small Companies, Till 2035 (USD Million)
  • Figure 12.7 Cell Cytometry Market for Small Companies, Till 2035 (USD Million)
  • Figure 12.8 Cell Cytometry Market for Mid-sized Companies, Till 2035 (USD Million)
  • Figure 12.9 Cell Cytometry Market for Large Companies, Till 2035 (USD Million)
  • Figure 12.10 Cell Cytometry Market for Very Large Companies, Till 2035 (USD Million)
  • Figure 12.11 Global Cell Cytometry Market: Distribution by Key Geographical Regions
  • Figure 12.12 Cell Cytometry Market in North America, Till 2035 (USD Million)
  • Figure 12.13 Cell Cytometry Market in Europe, Till 2035 (USD Million)
  • Figure 12.14 Cell Cytometry Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 12.15 Cell Cytometry Market in Rest of the World, Till 2035 (USD Million)
  • Figure 13.1 Concluding Remarks: High Throughput Flow Cytometers Market Landscape
  • Figure 13.2 Concluding Remarks: Image Cytometers Market Landscape
  • Figure 13.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 13.4 Concluding Remarks: Funding and Investment Analysis
  • Figure 13.5 Concluding Remarks: Global Events
  • Figure 13.6 Concluding Remarks: Patent Analysis
  • Figure 13.7 Concluding Remarks: Market Forecast